Dr. Amit Garg shares his experience with the unique challenges of disease assessment and measuring treatment response in Hidradenitis Suppurativa.

At Thalocan Research Innovations we collaborate with experts like Dr. Garg and Dr. John Ingram, among others, to develop tools and applications that improve the experience for trialists and patients, as well as optimizing the data collection process to capture better quality of endpoint data.

Learn more at our booth at hashtag#SHSA2025 presented by Hidradenitis Suppurativa Foundation (HFS) and the Canadian Hidradenitis Suppurativa Foundation (CHSF)